Scientists are bringing precision medicine to rheumatoid arthritis for the first time by using genetic profiling of joint tissue to see which drugs will work for which patients, reports a new Northwestern Medicine multi-site study.
In the near future, patients won’t have to waste time and be disappointed with months of ineffective therapy, scientists said.
“Now we can start to predict which drugs a patient will respond to,” said co-senior author Harris Perlman, chief of rheumatology at Northwestern University Feinberg School of Medicine. “We can truly do precision medicine for rheumatoid arthritis. I believe this could be game changing. ”
The paper was recently published as an uncorrected proof in Arthritis & Rheumatology and will be officially published in the journal in late May. Richard Pope and Deborah Winter also are lead Northwestern authors.
Treatment for rheumatoid arthritis now is trial and error.
“We have so many different biologic drugs and there’s no rhyme or reason to give one drug versus the other,” Perlman said. “We waste $2.5 billion a year in ineffective therapy. And patients go through 12 weeks of therapy, don’t respond and get upset.”
Scientists in the multi-site study were the first in the U.S. to use ultrasound-guided therapy to take a tissue biopsy in the affected joint. In the past, blood samples were used to try to determine the effectiveness of the therapy and disease progression.
“It’s just like oncology, where you go to the tumor,” Perlman said. “Why go anywhere else? In rheumatoid arthritis, we’ve never gone to the target organ.”
Improved ultrasound guided techniques make the new technique possible, Perlman said, noting joint biopsies began in Europe about six years ago.
Scientists in the six-site study analyzed the tissue in 41 rheumatoid arthritis patients, separating out different immune cell populations. They focused on macrophages, essentially the garbage collectors of the immune system that are overactive in rheumatoid arthritis. These cells produce toxic, inflammatory proteins that destroy the joints. Biologic therapy removes the protein molecules being secreted by the macrophages.
The study included 30 patients from Northwestern and the remaining 11 from the University of Alabama at Birmingham; Washington University, Columbia University, Mayo Clinic and University of Michigan.
In the past, scientists have tried to determine therapeutic effectiveness by separating patients into groups based on their clinical parameters such as what antibodies they are producing against themselves, how swollen their joints are and medications they are taking. Then scientists tried to see if these parameters could predict therapeutic efficacy. But that hasn’t worked, Perlman said.
Instead, Perlman and colleagues segregated patients based on the genes being produced by their macrophages. They identified two patient groups who shared aspects of the genetic profiles.
Next, the scientists identified which of these patient populations had joints that were getting better and what biologic therapies they were taking. They also identified a gene sequence associated in patients with early disease. The earlier the patient is treated, the more effective the therapy.
The next goal is to predict which patients will have the best response — based on their genetic signature — to a specific drug.
In a new study, researchers are taking joint biopsy tissue from patients at the start of a new therapy and then six weeks later to see if they can find a predictor gene sequence that will clearly identify which patients respond to a particular therapy.
“The idea is to develop gene sequences to predict whether a patient will respond or not,” Perlman said. “Our goal is that this procedure will become the standard of care of for all patients with rheumatoid arthritis.”
Learn more: Rheumatoid arthritis meets precision medicine
The Latest on: Rheumatoid arthritis
via Google News
The Latest on: Rheumatoid arthritis
Musculoskeletal Disorders Pipeline Database 2018: Osteoporosis, Rheumatoid Arthritis, Systemic Lupus Erythematosus, and Ankylosing Spondylitis
on April 18, 2018 at 12:42 pm
The "Musculoskeletal Disorders Pipeline Database - 2018" report has been added to ResearchAndMarkets.com's offering. Musculoskeletal Disorders Pipeline Highlights Database - 2018, provides most up-to-date information on key pipeline products in the global ... […]
FDA Panel on Lilly’s Arthritis Drug Is the Next Big Test for Biotech Investors
on April 18, 2018 at 11:56 am
Biopharma investors face another test next week as a highly anticipated U.S. Food and Drug Administration advisory panel is set to spark moves in shares of Eli Lilly & Co., Incyte Corp. and other companies developing medicines for rheumatoid arthritis. […]
Conflicting evidence on the efficacy of dietary interventions on rheumatoid arthritis: Review
on April 18, 2018 at 9:16 am
Certain dietary factors may have an impact on rheumatoid arthritis, but extensive research is needed to determine this, according to a recent review article. Rheumatoid arthritis patients tend to seek dietary advice from their doctors, and many undertake ... […]
12 Rheumatoid Arthritis Symptoms You Can't Ignore
on April 18, 2018 at 8:17 am
Another morning and you’re stuck under the covers feeling achy all over. Your fingers barely budge, and your feet are tender. It will take a while to get your bones up and moving because every step is painful, at least until you’ve had a long, hot shower. […]
Study on arthritis prevalence and trends reveals unexpected findings
on April 17, 2018 at 6:40 pm
The most common form of arthritis is osteoarthritis (OA), which often affects the knees, hips and lower back. Rheumatoid arthritis (RA), an autoimmune disease, can lead to structural damage, deformity and disability. About 75 percent of those affected by ... […]
Will a Recent Rheumatoid Arthritis Drug Approval See Rekindled Interest?
on April 17, 2018 at 8:35 am
While the approved RA drugs may lower inflammation and pain, prevent joint damage and slow the progression and pain, unfortunately there is no cure for RA. Roughly 1.3 million Americans have the disease, and 41 of every 100,000 people are diagnosed with RA ... […]
Arthritis pain: Eating this hard food may reduce symptoms
on April 17, 2018 at 6:16 am
ARTHRITIS, rheumatoid arthritis and other types of the condition have symptoms including pain and discomfort. There is no cure but you can take several steps to reduce the symptoms, such as changing your diet. Some foods are better than others. […]
Here’s How to Travel When You Have Arthritis
on April 13, 2018 at 2:04 pm
Rheumatoid arthritis and other arthritic conditions can make traveling more challenging. But there are ways to make it a little easier. From spring break to summertime, travel season is upon us. While jet-setting or road-tripping may invoke excitement in ... […]
Is scaling and root planing effective for treating rheumatoid arthritis?
on April 12, 2018 at 12:24 am
April 12, 2018-- Research suggests links between periodontal disease and rheumatoid arthritis, so might scaling and root planing reduce signs of both diseases in patients with both conditions? To find out, investigators compared the effects of this ... […]
via Bing News